Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the company to reconsider the drug’s future.

By Katherine Hamilton Viatris's said on Friday that the trial of an ointment for people with blepharitis didn't meet its primary endpoint.

Viatris Inc., a global healthcare company, announced that a randomized, double-masked, vehicle-controlled, phase 3 study to evaluate the efficacy and safety of pimecrolimus 0.3% (MR-139) ophthalmic ...

Mt. Washington Pediatric Hospital held a toy drive on Thursday in efforts to stock up for its annual Holiday Toy Shop, helping patient families in need.

A Connecticut university has announced a new pediatric nursing scholarship honoring the life and legacy of Jennifer Lynn Hawke-Petit.

On Tuesday, officials confirmed that a pediatric patient has died from Naegleria fowleri, also known as the brain-eating amoeba.

Darren Till and Luke Rockhold are already itching to get their hands on each other at Misfits Boxing 22.

Viatris Chief R&D Officer Philippe Martin said, "Given that the study did not meet its objective for patients suffering from blepharitis, we are evaluating the appropriate next steps for the Phase ...

Florida State University's Institute for Pediatric Rare Diseases (IPRD) and Sunshine Genetics Pilot Program received $7.5 million in state funding for a newborn genetic screening pilot program.

Find the latest Pediatrics news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.

The use of dexmedetomidine reduces the need for opioids and the likelihood of emergence delirium in children undergoing tonsillectomy under general anesthesia, a meta-analysis shows.

Eyelash mites, microscopic arachnids, commonly reside on our faces, particularly around the eyes. While often harmless, an overgrowth can lead to Demodex blepharitis, causing itchy, red, and ...